Breathe Well Live Well
|
Asthma drug appears to rejuvenate elderly brains, rodent study finds
ScienceAlert New research in rats has shown that a cheap drug used to prevent asthma attacks could also help our brains to fight the symptoms of old age – including memory loss, inflammation, and loss of cognitive performance. The drug, known as montelukast, was … |
View full post on asthma – Google News
| Related Articles |
ERJ November Podcast: results from the adult and paediatric cohorts of the U-BIOPRED study of severe asthma.
Eur Respir J. 2015 Nov;46(5):E59
Authors:
PMID: 26521291 [PubMed – in process]
View full post on pubmed: asthma
TIME |
Kids With Dogs Are Less Likely to Have Asthma, Study Says
TIME Exposure to dogs (having a parent who was a registered dog owner) during the first year of life was linked to a 13% lower risk of asthma in school age children, and farm animal exposure was linked to a 52% lower risk for school age children and a 31 … More Evidence that Dogs Prevent Asthma Pet dogs 'may help children avoid asthma' Could the family dog lower your child's asthma risk? |
View full post on asthma – Google News
Express.co.uk |
Growing up with pets and animals chops risk of children getting asthma, study …
Express.co.uk The findings lend strong support to the "hygiene hypothesis" that suggests living in too-clean conditions early in life can increase susceptibility to allergy conditions such as asthma. Scientists analysed data on more than one million children born … |
View full post on asthma – Google News
  |
Related Articles |
Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.
J Psychosom Res. 2015 Oct 13;
Authors: Heller MK, Chapman SC, Horne R
Abstract
OBJECTIVE: Some perceived medication side effects may be ‘normal’ symptoms that patients misattribute to the medication. Using an analogue approach, we tested if medication beliefs predict whether participants misattribute a headache as a side effect and subsequently intend to stop medication.
METHODS: We recruited 690 participants, 223 reporting a past asthma diagnosis. They received information about asthma and Molair, a fictitious asthma treatment modeled on a licensed treatment (montelukast). We varied the description of efficacy and side effects (which did not include headache). Pre-exposure to this information, participants completed the Beliefs about Medicine Questionnaire (BMQ)-General and the Perceived Sensitivity to Medicines Scale (PSM), post-exposure they completed the BMQ-Specific. Participants were asked to imagine they experienced a headache while taking Molair. Finally, they rated whether the headache was a side effect (misattribution) and if they would stop taking Molair (behavioral intention).
RESULTS: Nearly a quarter (170) of participants misattributed the headache to Molair and 69 (10%) subsequently intended to stop Molair. Both outcomes were predicted by general and specific medication beliefs. Odds of misattribution (m) and behavioral intention (i) increased with higher General Harm (ORm=1.90, ORi=2.72), General Overuse (ORm=1.74, ORi=1.56) and Molair Concern beliefs (ORm=1.52, ORi=1.78, all p<.01), but decreased with General Benefit (ORm=0.72, ORi=0.53) and Molair Necessity beliefs (ORm=0.72, ORi=0.70, all p<.05).
CONCLUSION: Symptom misattribution and subsequent intentions to stop Molair were predicted by pre-exposure beliefs about medicines in general and post-exposure beliefs about Molair. Patients with negative medication beliefs may be prone to misattribute symptoms and subsequently stop medication.
PMID: 26519128 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Condition: Tinea
Interventions: Drug: Ketoconazole + betamethasone dipropionate; Drug: Clotrimazole + Dexamethasone acetate
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Cystic Fibrosis
Interventions: Drug: N91115; Drug: Placebo
Sponsors: Nivalis Therapeutics, Inc.; Medidata Solutions
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
ChristianToday |
Asthma drug a potential treatment for aging brains, according to new study
ChristianToday A new study has found that a drug originally intended for the management of asthma attacks has been found to rejuvenate the aging brain. The study, conducted by researchers at Paracelsus Medical University in Austria and published in Nature … Affordable asthma medicine to treat dementia |
View full post on asthma – Google News
Food World News |
New Study: Asthma Pills Rejuvenate Ageing Brain
Food World News Scientists have found out that montelukast, which is used to keep asthma attacks in children and adults is capable to reverse the brain's ageing process in rats. This could lead to decreasing the rate of deterioration of the human brain or even … |
View full post on asthma – Google News
|
Exercise Improves Asthma Control, Study Suggests
Medscape MONTREAL — In relatively unfit adults, 12 weeks of aerobic exercise significantly improved asthma control, according to preliminary results from the randomized Impact of Aerobic Exercise on Asthma Morbidity (Ex-Asthma) study. This finding suggests … |
View full post on asthma – Google News